Search Results - "ASBURY, R. F"

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group study (PZ586) by Tester, William J., Kim, Kyung Mann, Krigel, Robert L., Bonomi, Philip D., Glick, John H., Asbury, Robert F., Kirkwood, John M., Blum, Ronald H., Schiller, Joan H.

“…Interleukin-2 (IL-2) and beta-interferon (β-IFN) are biologic agents with antitumor activity observed in preclinical models. Some studies of patients with…”
Get full text

Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study by Chang, A Y, Boros, L, Garrow, G C, Asbury, R F, Hui, L

“…Ifosfamide, carboplatin, cisplatin, etoposide, and paclitaxel are chemotherapeutic agents active in treating many malignant diseases. The ICE combination…”
Get more information

Phase II trial of trimetrexate for patients with advanced gastric carcinoma : An Eastern Cooperative Oncology Group Study (E1287) by RAMANATHAN, R. K, LIPSITZ, S, ASBURY, R. F, QAZI, R, GREENBERG, B. R, HALLER, D. G

“…A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated…”
Get full text

Treatment of squamous cell esophageal cancer with topotecan: An Eastern Cooperative Oncology Group Study (E2293) by ASBURY, R. F, LIPSITZ, S, GRAHAM, D, FALKSON, C. I, BAEZ, L, BENSON, A. B

“…Seventeen patients with enhanced measurable squamous cell carcinoma of the esophagus were treated with topotecan 1.5 mg/m2 daily for 5 days repeated every 21…”
Get full text

A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer by WITTE, R. S, LIPSITZ, S, GOODMAN, T. L, ASBURY, R. F, WILDING, G, STRNAD, C. M, SMITH, T. J, HALLER, D. G

“…Twenty-four previously untreated, ambulatory patients with advanced colorectal carcinoma were treated with either caracemide (11 patients) or homoharringtonine…”
Get full text

An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer by Asbury, R F, Cnaan, A, Johnson, L, Harris, J, Zaentz, S D, Haller, D G

“…There were 80 patients with measurable metastatic or unresectable pancreatic cancer randomly assigned to treatment with either DHAD, VP-16, aclacinomycin, or…”
Get more information

A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix by Asbury, R F, Blessing, J A, Soper, J T

“…Twenty evaluable patients with squamous cell carcinoma of the cervix, who had previously received a cisplatin-containing regimen, were treated with amonafide…”
Get more information

Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide by Boros, L, Garrow, G C, Asbury, R F, Chang, A Y

“…The combination of ifosfamide (with mesna uroprotection), carboplatin, and etoposide (ICE) has demonstrated activity in a variety of cancers. Paclitaxel…”
Get more information

A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancer by Asbury, R F, Blessing, J A, Look, K Y, Clarke-Pearson, D, Homesley, H D

“…In this study, 19 evaluable patients with epithelial ovarian cancer were treated with amonafide 300 mg/m2 over an hour for 5 consecutive days every 3 weeks…”
Get more information

Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group by Asbury, R F, Blessing, J A, McGuire, W P, Hanjani, P, Mortel, R

“…Twenty-one evaluable patients with advanced carcinoma of the endometrium were treated with aminothiadiazole at a dosage of 125 mg/m2 weekly. Twelve had…”
Get more information

Pharmacokinetics of very high-dose oral melphalan in cancer patients by Boros, L, Peng, Y M, Alberts, D S, Asbury, R F, Goodman, T L, Penn, T E, Hickox, D E

“…The pharmacokinetics and systemic availability of melphalan after high-dose oral administration with and without 1,3-bis(2-Chloroethyl)-1-nitrosourea (BCNU) or…”
Get more information

Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group by Asbury, R F, Blessing, J A, Mortel, R, Homesley, H D, Malfetano, J

“…Twenty-one evaluable patients with advanced squamous-cell cervical cancer were treated with aminothiadiazole at a dosage of 125 mg/m2 weekly. Nineteen had…”
Get more information

A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study by Pandya, K J, Kramar, A, Asbury, R F, Haller, D G

“…Thirty-one patients with advanced colorectal cancer were entered on a phase II study of spirogermanium. Of these, 23 received the drug at the dose of 200 mg/m2…”
Get more information

A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer by Ransom, D T, Neuberg, D, Loprinzi, C L, Tormey, D C, Blum, R H, Harris, J E, Asbury, R F, Falkson, G

“…The aim of this pilot study was to estimate the toxicity and response rate of an alternating chemotherapeutic program in chemotherapy-naive metastatic breast…”
Get more information

5-Fluorouracil and high-dose folic acid treatment for metastatic colon cancer by Asbury, R F, Boros, L, Brower, M, Woll, J, Chang, A, Bennett, J

“…Twenty-two patients with metastatic colorectal cancer were treated with a regimen of 5-fluorouracil 600 mg/m2 (maximum, 1.0 g) i.v./week and folic acid 140…”
Get more information

Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group by Asbury, R F, Wilson, J, Blessing, J A, Buchsbaum, H J, DiSaia, P J

“…Thirty-two evaluable patients with advanced epithelial ovarian cancer were treated with aminothiadiazole at a dosage of 125 mg/m2 weekly. Two patients had…”
Get more information

Leukemic dermal infiltrates as a complication of central venous catheter placement by Amiraian, R, Penn, T E, Hamann, S, Asbury, R F, Boros, L, Markowitch, W, Goodman, T L

“…A leukemic dermal infiltrate at the site of a central venous catheter placement was the first manifestation of relapse in a 58-year-old woman in clinical…”
Get more information

Long-term survival in limited-stage small cell lung carcinoma. Experience in Rochester, New York from 1975 to 1981 by George, T K, Fitzgerald, D, Brown, B S, Chuang, C, Asbury, R F, Boros, L

“…All patients with limited-stage small cell lung carcinoma (SCLC) diagnosed between January 1975 and 1981 in Rochester, New York, were collected. One hundred…”
Get more information

Soluble adenylate cyclase from thyroid membranes by Asbury, R F, Cook, G H, Wolff, J

“…Adenylate cyclase from purified beef thyroid membranes has been solubilized by the use of Triton N-101 after preactivation with guanosine 5'-(beta,…”
Get full text

Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group by Asbury, R F, Blessing, J A, DiSaia, P J, Malfetano, J

“…Twenty-six evaluable patients with advanced nonsquamous cell cervical cancer were treated with aminothiadiazole at a dosage of 125 mg/m2 weekly. Sixteen had…”
Get more information